Scios Inc. (JNJ) Announces Agreement with Department of Justice Regarding NATRECOR(R)
10/6/2011 11:13:44 AM
More...
|
Study Finds Scios Inc. (JNJ)'s Heart Failure Drug, Natrecor, Ineffective
7/7/2011 7:07:27 AM
More...
|
Scios Inc. (JNJ) Announces Results of ASCEND Heart Failure Study at the Scientific Sessions of the American Heart Association
11/15/2010 11:34:58 AM
More...
|
Two Drugs For Heart Failure Show Mixed Results; Novartis Pharmaceuticals Corporation (NVS)'s Diovan Should Be Used More Often And Scios Inc. (JNJ)'s Natrecor Should Not Be Used At All, VA Medical Center And Baylor University Research Shows
5/22/2008 7:36:39 AM
More...
|
Scios Inc. (JNJ) Announces Enrollment of First Patients in ASCEND-HF Trial in Acute Heart Failure
6/8/2007 11:08:48 AM
More...
|
Scios Inc. (JNJ) Announces Selection Of Independent Executive Committee And Planned Protocol Design For The ASCEND-HF Landmark International Outcomes Trial Of NATRECOR(R) (nesiritide)
11/13/2006 2:59:52 PM
More...
|
Investigators Report New Renal, Mortality And Safety Data; Johnson & Johnson (JNJ) Says Natrecor Meets Goals In Midstage Trial
9/11/2006 11:37:21 AM
More...
|
Johnson & Johnson (JNJ) Unit Orders Heart Failure Drug Test
9/8/2006 9:00:36 AM
More...
|
The Day In Review: Pfizer Inc. (PFE) Returns Indiplon To Neurocrine Biosciences, Inc. (NBIX)
6/23/2006 6:02:29 PM
More...
|
Johnson & Johnson (JNJ) To Shut Down Fremont Scios Inc. (JNJ) Unit; Lays Off 500 Workers From Scios And ALZA Corporation (JNJ)
6/23/2006 11:49:59 AM
More...
|
|